小结
定义
病史和体格检查
关键诊断因素
- presença de fatores de risco
- rubor
- eritema
- pápulas e pústulas
- telangiectasias
- manifestações oculares
- formação de placas
- distribuição na face
- mudanças fimatosas
其他诊断因素
- acne vulgar
- queimação ou ardência
- aparência ressecada
- edema
- localização periférica
危险因素
- Fototipos cutâneos I ou II da escala Fitzpatrick
- banhos/duchas quentes
- extremos de temperatura
- luz do sol
- estresse emocional
- bebidas quentes
- história familiar
- sexo feminino
- alimentos picantes
- bebidas alcoólicas
- medicamentos
诊断性检查
首要检查
- diagnóstico clínico
需考虑的检查
- biópsia de pele
- título de fator antinuclear
治疗流程
todos os pacientes
撰稿人
作者
Abel D. Jarell, MD
Dermatologist and Dermatopathologist
Northeast Dermatology Associates
Principal Investigator
ActivMed Research
Portsmouth
NH
利益声明
ADJ declares that he has no competing interests.
鸣谢
Dr Abel D. Jarell would like to gratefully acknowledge Dr Alexa Boer Kimball, a previous contributor to this topic.
利益声明
ABK has received honoraria for consulting from Intendis and has been an investigator for Intendis and Bayer.
同行评议者
Jashin J. Wu, MD
Chief Dermatology Resident
University of California
Irvine
CA
利益声明
JJW declares that he has no competing interests.
Paradi Mirmirani, MD
Physician
Department of Dermatology
Kaiser Permanente Vallejo Medical Center
Vallejo
CA
利益声明
PM declares that she has no competing interests.
Brian L. Swick, MD
Assistant Clinical Professor of Dermatology and Pathology
University of Iowa
Iowa City
IA
Declarações
BLS declares that he has no competing interests.
Thierry Simonart, MD, PhD
Physician
Department of Dermatology
Erasme University Hospital
Brussels
Belgium
Declarações
TS declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Referências
Principais artigos
Gallo RL, Granstein RD, Kang S, et al. Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2018 Jan;78(1):148-55. Resumo
Hampton PJ, Berth-Jones J, Duarte Williamson CE, et al. British Association of Dermatologists guidelines for the management of people with rosacea 2021. Br J Dermatol. 2021 Oct;185(4):725-35.Texto completo Resumo
Del Rosso JQ, Tanghetti E, Webster G, et al. Update on the management of rosacea from the American Acne & Rosacea Society (AARS). J Clin Aesthet Dermatol. 2020 Jun;13(6 suppl):S17-S24.Texto completo Resumo
Thiboutot D, Anderson R, Cook-Bolden F, et al. Standard management options for rosacea: the 2019 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2020 Jun;82(6):1501-10. Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
Diagnósticos diferenciais
- Dermatite seborreica
- Dermatite de contato
- Lúpus eritematoso sistêmico
Mais Diagnósticos diferenciaisDiretrizes
- Guidelines for the management of people with rosacea
- Management of rosacea
Mais DiretrizesFolhetos informativos para os pacientes
Rosácea: quais são as opções de tratamento?
Rosácea: o que é?
Mais Folhetos informativos para os pacientes
Conectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal